# Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Tributyrin Supplementation

> **NCT05446168** · PHASE1 · TERMINATED · sponsor: **Nicolaas Bohnen, MD, PhD** · enrollment: 18 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** tributyrin

## Key facts

- **NCT ID:** NCT05446168
- **Lead sponsor:** Nicolaas Bohnen, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-07-01
- **Primary completion:** 2023-09-26
- **Final completion:** 2023-09-26
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Withdrawal of funding
- **Last updated:** 2025-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05446168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05446168, "Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Tributyrin Supplementation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05446168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*